ClinicalTrials.Veeva

Menu

Gluteus Medius Latent Trigger Point and Muscle Strength in Healthy Subjects

K

Kars State Hospital

Status

Completed

Conditions

Muscle Weakness
Myofascial Pain Syndrome

Treatments

Device: Muscle strength measurement

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aimed to investigate the relationship between latent MTrPs and gluteus medius muscle strength in a group of healthy adults.

Full description

Latent myofascial trigger points (MTrPs) do not cause spontaneous pain; however, they may lead to a limited range of motion and muscle weakness. We hypothesized that latent MTrPs might decrease gluteus medius muscle strength in healthy individuals. Forty-eight healthy men will be included in the study. Trigger point examination for the gluteus medius will be performed bilaterally. Subjects with one or more trigger points on the dominant side and those without any trigger points will be assigned to two groups. Muscle strength for gluteus medius will be assessed with a manual muscle tester using the "break test" technique on both sides. The subjects and the examiners will be blinded. For statistical analysis, the independent sample t-test was used to compare the intergroup differences.

Enrollment

48 patients

Sex

Male

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient age: 18-40 years.
  • Absence of musculoskeletal complaints related to the lumbar, sacroiliac, and hip area.
  • Absence of bilateral latent MTrP in the gluteus medius muscle.
  • Latent trigger point in the gluteus medius muscle on the dominant side with palpation.

Exclusion criteria

  • A history of medical treatment, physical therapy, injection therapy, or surgical treatment related to the lumbar, sacroiliac, and hip area.
  • History of trauma, or malignancy or being pregnant, or if the patient is in the lactation period.
  • Bilateral latent MTrP in the gluteus medius muscle.
  • Presence of latent MTrP on the non-dominant side.

Trial design

48 participants in 2 patient groups

Group 1. Latent Myofascial Trigger Point Group
Description:
24 participants who will be clinically diagnosed with unilateral latent myofascial trigger point in the dominant side gluteus medius muscle.
Treatment:
Device: Muscle strength measurement
Group 2. Non-Latent Myofascial Trigger Point Group
Description:
24 participants who don't have latent myofascial trigger point.
Treatment:
Device: Muscle strength measurement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems